Cilostazol Mediates Immune Responses and Affects Angiogenesis During the Acute Phase of Hind Limb Ischemia in a Mouse Model

Efthymios Paronis,Michalis Katsimpoulas,Nikolaos P. E. Kadoglou,Claire Provost,Marianna Stasinopoulou,Christos Spyropoulos,Elpida Poulaki,Aurélie Prignon,Ioannis Kakisis,Nikolaos Kostomitsopoulos,Penelope Bouziotis,Ioannis Kostopoulos,Ourania E. Tsitsilonis,Andreas C. Lazaris

Cilostazol Mediates Immune Responses and Affects Angiogenesis During the Acute Phase of Hind Limb Ischemia in a Mouse Model

2020

Efthymios Paronis
Michalis Katsimpoulas
Nikolaos P. E. Kadoglou
Claire Provost
Marianna Stasinopoulou
Christos Spyropoulos
Elpida Poulaki
Aurélie Prignon
Ioannis Kakisis
Nikolaos Kostomitsopoulos
Penelope Bouziotis
Ioannis Kostopoulos
Ourania E. Tsitsilonis
Andreas C. Lazaris

Background:Cilostazol is a drug of choice for the treatment of intermittent claudication that also affects innate and adaptive immune cells. The purpose of our study was the evaluation of cilostazo...

Keywords:

Internal medicine
Diabetes mellitus
Angiogenesis
hind limb ischemia
Peripheral ischemia
Immune system
Cilostazol
Medicine
Cardiology
Intermittent claudication
cytokine profile

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations